Ms. Mahal joined Bain Capital Life Sciences in 2018. She is an Associate.
Prior to joining Bain Capital Life Sciences, Ms. Mahal spent several years across different functions at Biogen: Global Commercial Strategy, Corporate Development and Strategy, and Research and Development Strategy. As part of these functions, Ms. Mahal was responsible for M&A landscapes and prioritization, due diligence, corporate growth strategy, therapeutic and disease area strategies, and portfolio prioritization and governance.
Ms. Mahal graduated with high honors from Boston University Healthcare Management Program. She received an MS in Molecular Biology from the International Max Planck Research School at University of Göttingen and a BS in Biotechnology from Guru Gobind Singh Indraprastha University, Delhi.